Article
The GigaAssay: A combined high throughput and highly accurate platform for variant classification.
New biotechnology - 25 May 2026
Giacoletto Christopher J, Valente Liz J, Brown Lancer, Patterson Sara, Gokhale Rewatee, Mockus Susan M, Grody Wayne W, Deng Hong-Wen, Rotter Jerome I, Schiller Martin R
Abstract excerpt
ERBB2 (HER2) is a critical oncogene, yet the comprehensive and standardized assessment of its variant effects, particularly concerning receptor tyrosine kinase function, remains a major challenge. To compare the oncogenic potential of benchmark variants, we utilized the GigaAssay, a modular high-throughput one-pot assay system capable of simultaneously measuring their molecular function. We designed the GigaAssay...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
